Ebola vaccine trial launches in Democratic Republic of Congo
On 21 September 2026, an Ebola vaccine trial began in the Democratic Republic of the Congo involving frontline health workers and other responders. The trial uses the Ervebo vaccine and represents a key public health initiative in an Ebola-affected region.